ALXO - ALX Oncology GAAP EPS of -$1.24 misses by $0.37
2023-11-14 01:51:28 ET
More on ALX Oncology
- ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept
- ALX Oncology Holdings: Gilead News Creates A New Risk
- ALX Oncology stock rockets 27% after being halted for volatility
- ALX Oncology announces pricing of its public offering
- Seeking Alpha’s Quant Rating on ALX Oncology
For further details see:
ALX Oncology GAAP EPS of -$1.24 misses by $0.37